CRISPR-Cascade test detects bloodstream infections in minutes without amplification
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting bloodstream infections in minutes without the need for nucleic acid amplification. The CRISPR-Cascade assay achieves attomolar sensitivity and incorporates an OR-gated logic function to identify multiple pathogens simultaneously through DNA from pathogens associated with bloodstream infections. Bloodstream infections require rapid identification to prevent complications, yet standard diagnostic methods rely on...
Related Coverage
AllSides Picks
Headline Roundup
FAA Rolls Out AI Air Traffic Control System for DC Airports
September 21st, 2026
Headline Roundup
How Do Americans Feel About AI?
September 15th, 2026
Story of the Week
Should We Slow AI Development?
AllSides Staff
September 17th, 2026
Recommended Reading
When Americans Are Afraid of the Future
Dan Schnur
August 31st, 2026